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Abstract
Mutations in Pten-induced kinase 1 (PINK1) are linked to early-onset familial Parkinson’s disease (FPD). PINK1 has previously
been implicated in mitochondrial fission/fusion dynamics, quality control, and electron transport chain function. However, it
is not clear how these processes are interconnected and whether they are sufficient to explain all aspects of PINK1
pathogenesis. Here we show that PINK1 also controls mitochondrial motility. In Drosophila, downregulation of dMiro or
other components of the mitochondrial transport machinery rescued dPINK1 mutant phenotypes in the muscle and
dopaminergic (DA) neurons, whereas dMiro overexpression alone caused DA neuron loss. dMiro protein level was increased
in dPINK1 mutant but decreased in dPINK1 or dParkin overexpression conditions. In Drosophila larval motor neurons,
overexpression of dPINK1 inhibited axonal mitochondria transport in both anterograde and retrograde directions, whereas
dPINK1 knockdown promoted anterograde transport. In HeLa cells, overexpressed hPINK1 worked together with hParkin,
another FPD gene, to regulate the ubiquitination and degradation of hMiro1 and hMiro2, apparently in a Ser-156
phosphorylation-independent manner. Also in HeLa cells, loss of hMiro promoted the perinuclear clustering of
mitochondria and facilitated autophagy of damaged mitochondria, effects previously associated with activation of the
PINK1/Parkin pathway. These newly identified functions of PINK1/Parkin and Miro in mitochondrial transport and mitophagy
contribute to our understanding of the complex interplays in mitochondrial quality control that are critically involved in PD
pathogenesis, and they may explain the peripheral neuropathy symptoms seen in some PD patients carrying particular
PINK1 or Parkin mutations. Moreover, the different effects of loss of PINK1 function on Miro protein level in Drosophila and
mouse cells may offer one explanation of the distinct phenotypic manifestations of PINK1 mutants in these two species.
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Introduction
PD is a neurodegenerative disorder characterized by the
dysfunction and lossofdopaminergic (DA) neuronsin the substantia
nigra, although neurons in other brain regions are affected as well.
Mutations in PINK1 and Parkin are linked to familial forms of early-
onset PD [1,2]. PINK1 encodes a Ser/Thr kinase with a
mitochondrial targeting sequence, whereas Parkin encodes an E3
ubiquitin ligase. Studies in Drosophila first revealed that PINK1 and
Parkin act in a common pathway to impact mitochondrial function
and DA neuron maintenance [3–6], in part through the regulation
ofmitochondrialfission/fusiondynamics[7–11].Atleastinprimary
cultured mammalian hippocampal neurons and DA neurons,
PINK1 and Parkin have been shown to exert similar effects on
mitochondrial dynamics as seen in Drosophila DA neurons [7,12].
PINK1 and Parkin are also implicated in mitochondrial quality
control [13]. Decreased mitochondrial membrane potential stabi-
lizes the normally labile PINK1, which recruits Parkin to damaged
mitochondria, leading to ubiquitination of mitochondrial proteins
and marking damaged mitochondria for removal by autophagy
[14]. Both mitochondrial fission/fusion dynamics and autophagy
are considered important aspects of the mitochondrial quality
control mechanism that mediates PINK1/Parkin function in DA
neuron maintenance [11,15–17].
In some PINK1-o rParkin-linked PD patients, symptoms of
peripheral neuropathy were also reported [18–20]. It is not clear
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or some other unknown function of PINK1/Parkin. Peripheral
neuropathy is a clinical term used to describe various forms of
damages to nerves of the peripheral nervous system by distinct
mechanisms [21]. Many types of peripheral neuropathy are
dependent on the length of neuronal axon, with neurons carrying
long axons frequently affected. It is hypothesized that this is caused
by defects in the axonal transport of key proteins and/or
organelles such as mitochondria, which are critical for maintaining
the axonal and synaptic physiology of those extremely polarized
neurons [22]. This notion has gained significant support from
recent studies of the inherited forms of peripheral neuropathies
[22,23]. Defective mitochondrial transport has also been consid-
ered a pathogenic event in other neurodegenerative diseases
[22,24,25], including rodent models of PD [26,27]. In primary
cultured rat hippocampal neurons, overexpression of PINK1 has
been shown to inhibit the lateral movement of photoactivated,
mito-Dendra2-labelled mitochondria [12], raising the possibility
that defects in the axonal transport of mitochondria may actively
participate in PINK1-related PD pathogenesis.
A major aspect of axonal transport is mediated by motor
proteins that travel on axonal microtubules, which are polarized
and uniformly orientated, with their plus-ends pointing towards
nerve terminals. The kinesin and dynein motors are involved in
microtubule plus-end (anterograde) and minus-end directed
(retrograde) transport, respectively [28]. Mitochondria are mainly
produced in neuronal cell body and delivered to sites where
metabolic demand is high, such as the synapses and nodes of
Ranvier [29]. The functions of Mitochondrial Rho (Miro), a
mitochondrial outer membrane GTPase [30], and the cytosolic
protein Milton are critical for mitochondrial transport, as they
serve to link mitochondria with kinesin motors and the
microtubule cytoskeleton [31,32]. In Drosophila Miro or Milton
mutants, mitochondria accumulate in neuronal soma and fail to
move into the axons [31,32]. In cultured mammalian cells,
overexpression of a constitutively active mutant of Miro was
shown to induce cell death, suggesting that mitochondrial
transport or some other aspect of Miro function is important for
cell survival [30]. Whether this is relevant to in vivo conditions such
as neurodegenerative disease settings is not known.
The fruit fly Drosophila melanogaster has served as an excellent
model for studying neurodegenerative diseases [10]. It was in
Drosophila that the in vivo function of PINK1 was first revealed [3–
6]. PINK1 mutant flies exhibit abnormal wing postures, reduced
flight ability and thoracic ATP level, degeneration of indirect flight
muscle and DA neurons, and male sterility, which are caused by
the accumulation of dysfunctional mitochondria, thus suggesting a
role of PINK1 in mitochondrial function and/or quality control
[3–6]. Further genetic studies in Drosophila have also uncovered
important functions of PINK1 in regulating mitochondrial
morphology and electron transport chain activity [7–9,33].
The power of the Drosophila neurodegenerative disease models
lies in the ability to facilitate unbiased genetic modifier screens to
identify new players involved in the disease process. Using this
approach, we show in this study that PINK1 genetically interacts
with the mitochondrial transport machinery. Reduction of
function in Miro, Milton, or kinesin heavy chain effectively
rescued the PINK1 mutant phenotypes. On the other hand,
overexpression (OE) of Miro led to the formation of enlarged
mitochondria and resulted in DA neuron loss, thus phenocopying
PINK1 mutants. By monitoring mitochondrial movement in live
Drosophila larval motor neurons, which possesses long axons and
could serve as a model system for studying peripheral neuropathy,
we provide evidence that PINK1 directly regulates mitochondrial
transport. The function of PINK1 in mitochondrial transport may
contribute to PD pathogenesis in DA neurons and underlie the
peripheral neuropathy symptoms associated with certain PINK1
mutations in some PD patients.
Our biochemical analysis demonstrated that overexpressed
PINK1 in cooperation with Parkin could regulate Miro protein
ubiquitination and stability, which might contribute to the
regulatory effect of PINK1 on mitochondrial motility. While our
paper was under review, it was suggested that PINK1 phosphor-
ylates Miro at a conserved S156 residue, and that this
phosphorylation event is required to activate proteasomal
degradation of Miro in a Parkin-dependent manner [34].
However, our in vitro kinase assay using active recombinant
PINK1 failed to show direct phosphorylation of Miro by PINK1.
Moreover, a mutant form of hMiro1 with the S156 site mutated to
Ala was equally susceptible to PINK1/Parkin-mediated degrada-
tion in HeLa cells. Thus, the exact molecular mechanism by which
the PINK1/Parkin pathway regulates Miro protein level will
require further investigation.
Results
Genetic interaction between PINK1 and the
mitochondrial transport machinery
By taking advantage of the easily identifiable phenotype of
abnormal wing posture induced by dPINK1 inactivation, we
performed a genetic screen for modifiers of PINK1. The scheme
was similar as described before [35]. In this screen, we identified
components of the mitochondrial transport machinery as genetic
modifier of PINK1. Knockdown of Miro, Milton or Kinesin heavy
chain (Khc) each rescued the muscle phenotypes in PINK1
B9 null
mutant, including abnormal wing posture, decreased fly ability
and ATP depletion (Figure 1A–1C). Conversely, overexpression
(OE) of Miro and Khc enhanced such phenotypes (Figure 1A–1C).
These results demonstrated strong genetic interaction between
PINK1 and the mitochondrial transport machinery as a whole,
supporting that mitochondrial transport is the underlying
Author Summary
Parkinson’s disease (PD) is the second most common
neurodegenerative disease. It mainly affects movement in
elderly people and was traditionally considered a sporadic
disease with no known cause. Discoveries of genes
associated with familial PD (FPD) have demonstrated that
PD pathogenesis can be significantly influenced by an
individual’s genetic makeup. Understanding the functions
of these FPD genes will allow better understanding of the
sporadic PD cases. PINK1 and Parkin are genes associated
with FPD that affect patients at an early age. Mutations in
PINK1 and Parkin lead to the accumulation of damaged
mitochondria, the powerhouse of the cell, as a result of
impairments of the mitochondrial quality control system.
However, the mechanism of PINK1/Parkin action remains
poorly understood. Here we show that PINK1 and Parkin
act together to regulate Miro, a key component of the
mitochondrial transport machinery, and that altered
activities of PINK1 cause aberrant mitochondrial transport.
Regulation of mitochondrial transport may be a critical
aspect of the mechanisms by which the PINK1/Parkin
pathway governs mitochondrial quality control. Dysfunc-
tion of this process could contribute to the loss of DA
neurons, the cardinal feature of PD, as well as the
peripheral neuropathy symptom associated with particular
PINK1 or Parkin mutations.
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will focus our analysis on Miro, as a previous study in cultured cells
suggested that mammalian Miro might physically interact with
PINK1 [36].
Genetic interaction between Miro and PINK1 in the PD–
relevant DA neurons
To test the relevance of the functional interaction between
PINK1 and the mitochondrial transport machinery to PD
pathogenesis, we examined their interaction in DA neurons, the
disease-relevant cell type. As in the muscle, Miro-RNAi effectively
rescued PINK1 mutant phenotypes in DA neurons, both in terms
of mitochondrial aggregation (Figure 2A–2D) and DA neuron loss
(Figure 2F). Moreover, Miro-OE alone, driven by the TH-Gal4
driver, caused aberrant mitochondrial aggregation (2E, 2G) and
DA neuron loss (Figure 2F), thus phenocopying PINK1 loss-of-
function effects (Figure 2B, 2F, 2G), although the Miro-OE effect
was noticeably stronger than PINK1 mutant. It is worth noting that
TH-Gal4-driven Miro-OE in PINK1 mutant background resulted
in dramatically reduced viability (data not shown), although the
surviving adults did not show further DA neuron loss than that
induced by Miro-OE alone (Figure 2F). Together, these results
demonstrate that PINK1 and Miro also exhibit strong genetic
interaction in DA neurons, with decreased dMiro level/activity
ameliorating the detrimental effects caused by the loss of dPINK1,
whereas increased dMiro level or activity phenocopying dPINK1
mutants.
PINK1 regulates mitochondrial motility in Drosophila
larval motor neurons
The strong genetic interaction between PINK1 and Miro raised
the interesting possibility that PINK1 might directly regulate
mitochondrial transport, the impairment of which might contrib-
ute to PINK1-related parkinsonism. This was further supported by
the DA neuron loss induced by Miro-OE alone, which presumably
acted by altering mitochondrial transport. To test this idea, we
examined the effect of PINK1 on mitochondrial movement in
Drosophila larval motor neurons, a system amenable to live imaging
of mitochondrial transport. Mitochondrially-targeted GFP (mi-
toGFP) expressed specifically in motor neurons was used to track
mitochondrial movement via live imaging in anesthetized third
instar larvae (Figure 3A), using well-established procedures
[37,38]. To highlight the mitochondria undergoing active
transport, a 61.5 mm-long segment of motor neuron was
photobleached and the movement of fluorescently labeled
mitochondria moving into the bleached area from both directions
was recorded at 1 frame/2 s for 300 s (Figure 3B, Videos S1, S2,
S3, S4, S5, S6, S7). From these videos, mitochondrial flux (the
normalized number of mitochondria that passes certain point over
time), mitochondrial net velocity (the normalized mitochondrial
net displacement over time), and mitochondrial morphology (e.g.
mitochondrial length) in different genetic backgrounds were
analyzed. In general, mitochondrial net velocity is controlled
primarily by the intrinsic properties and quantities of motor
proteins associated with the mitochondria [38], while mitochon-
drial flux can also be significantly affected by mitochondrial
morphology, as changes in mitochondrial morphological features
such as length can increase or decrease the number of motile
mitochondria.
We found that PINK1-OE decreased mitochondrial flux as well
as net velocity in both anterograde and retrograde directions,
similar to the effect of Miro-RNAi, although the PINK1-OE effect
appeared to be slightly weaker (Figure 3B–3D; Videos S1, S2, S4).
In contrast, PINK1-RNAi and Miro-OE both increased the net
velocity of anterograde mitochondrial transport, with retrograde
transport largely unaffected (Figure 3B, 3C; Videos S3, S5).
PINK1-RNAi also increased anterograde mitochondrial flux
(Figure 3C), while mitochondrial flux in Miro-OE background
was reduced in both anterograde and retrograde directions
(Figure 3C). The reduction of mitochondrial flux by Miro-OE
could be partially explained by the formation of very long
mitochondria in Miro-OE motor neurons (Figure 3E, 3F), as
previously observed [38].
In addition to mitochondrial motility, PINK1 also affected
mitochondrial length in motor neurons. PINK1-RNAi increased
Figure 1. Genetic interaction between PINK1 and the mito-
chondrial transport machinery in the muscle. Effects of knock-
down or overexpression of Miro, Milton or Khc on the abnormal wing
posture (A), jump/fly ability (B), and thoracic ATP level (C) of PINK1
B9
mutant are shown. Male flies of the corresponding genotypes were
scored at 1-day or 7-day of age at 25uC. Miro-RNAi
106683 was used for
the rest of studies. Data are from three independent experiments and
the results are presented as mean 6 s.e.m.
doi:10.1371/journal.pgen.1002537.g001
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Miro-OE case, although the effect of Miro-OE was much stronger.
Conversely, PINK1-OE and Miro-RNAi both decreased mito-
chondrial length (Figure 3E, 3F). To address whether PINK1-
induced mitochondrial motility change was due to its effect on
mitochondrial length, we examined mitochondrial transport in
genetic backgrounds where mitochondrial fusion/fission machin-
ery was directly manipulated to alter mitochondrial length.
Increasing mitochondrial fission by overexpression of the fission
protein Fis1 or knockdown of the fusion protein Marf led to
decreased mitochondrial length (Figure 3E, 3F), similar to the
effects of Miro-RNAi or PINK1-OE. However, in contrast to the
decreased mitochondrial flux and net velocity as observed in the
Miro-RNAi or PINK1-OE backgrounds, Fis1-OE and Marf-
RNAi both increased mitochondrial flux and net velocity in
anterograde and retrograde directions (Figure 3B–3D; Videos S6,
S7), suggesting that mitochondrial length and transport kinetics
are not always directly correlated, which is consistent with a
previous report [38]. Collectively, these results support the notion
that PINK1 regulates mitochondrial transport and that its effect
on mitochondrial motility is direct, rather than a secondary effect
of mitochondrial length change.
Altered PINK1 activities affect mitochondrial distribution
in motor neuron axons
In addition to mitochondrial motility, we also examined
mitochondrial distribution at motor neuron nerve terminals at
the larval neuromuscular junction (NMJ), which can be used as an
indirect measure of mitochondrial motility. Consistent with a
previous report [31], Miro-OE led to the accumulation of
mitochondria in the most distal boutons, which is likely the
consequence of net anterograde transport (Figure 4A, 4B). PINK1
knockdown showed similar effect (Figure 4A, 4B). Thus, the
dysfunctional mitochondria in PINK1 mutant might gain longer
retention time in the distal segment of motor neuron axons where
synapses are formed. This finding may have clinical implications
for PINK1 pathogenesis. In contrast, Miro-RNAi and PINK1-OE
both led to decreased accumulation of mitochondria in the most
distal boutons (Figure 4A, 4B). We conclude that PINK1 regulates
mitochondrial distribution in motor neuron nerve terminals, likely
through its effect on mitochondrial transport.
Overactivation of the PINK1/Parkin pathway reduces Miro
protein level
Our results so far showed that PINK1 and Miro exert opposite
effects on mitochondrial morphology, motility and distribution.
We next explored the biochemical mechanisms underlying their
negative genetic relationship. We first used HeLa cells to test
whether Miro protein level might be regulated by PINK1 and
possibly Parkin, which tends to work together with PINK1 in a
common pathway [3–5,39]. There are two Miro homologues in
human cells, hMiro1 and hMiro2, that are ,60% identical [30].
Overexpression of either hPINK1 or hParkin did not lead to
obvious change of exogenous hMiro1 protein level under normal
conditions, but a modest reduction of hMiro1 level was observed
when hPINK1 and hParkin were co-expressed (Figure 5A, lane 5).
A decline in mitochondrial membrane-potential induced by the
mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydra-
zone (CCCP) was reported to activate the PINK1/Parkin pathway
[13,14,39]. Under CCCP treatment condition, hPINK1 or
hParkin each significantly stimulated hMiro1 ubiquitination
(Figure 5A). Since HeLa cells express very little endogenous
Parkin [13], the effect of hPINK1 alone on hMiro1 ubiquitination
(Figure 5A, lane 8) suggested that other E3 ligase(s) might be
recruited by hPINK1 to ubiquitinate hMiro1. However, this
ubiquitination event did not appear to lead to destabilization of
Figure 2. Genetic interaction between PINK1 and Miro in DA neurons. (A–E) Mitochondrial morphology in DA neurons of different
genotyped flies visualized with mitoGFP expressed under TH-Gal4 control. Red: TH, green: GFP. DA neurons of the protocerebral posterior lateral 1
(PPL1) cluster were shown. Scale bar: 5 mm. (F) Effects of Miro-RNAi and Miro-OE on DA neuron maintenance in wild type and PINK1
B9 mutant
backgrounds. DA neuron number was scored in 14-day old flies. At least 5 flies were used for each genotype. (G) Mitochondrial-size distribution in DA
neurons of the various genotyped flies. Data are presented as mean 6 s.e.m.
doi:10.1371/journal.pgen.1002537.g002
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and hParkin dramatically reduced hMiro1 level in the presence of
CCCP (Figure 5A, lanes 9). Importantly, pathogenic mutations in
hPINK1 or hParkin abolished this effect (Figure 5B, lanes 4 and 5
compared with lane 3, and lanes 9–11 compared with lane 8),
indicating that functional hPINK1 and hParkin are both required
in the destabilization of hMiro1. Previously, many outer
mitochondrial membrane (OMM) proteins were shown to be
degraded by the ubiquitin proteasome system (UPS) pathway in a
PINK1/Parkin-dependent reaction at an early step of mitophagy,
while other OMM proteins might be eliminated by subsequent
autophagosome-dependent events [40,41]. Thus, direct or indirect
substrates of PINK1/Parkin could be distinguished by their
degradation kinetics [40]. In our experiments, hMiro1 was more
rapidly degraded than another OMM protein VDAC1 (Figure 5B,
VDAC1), a reported Parkin substrate involved in mitophagy [14],
supporting that hMiro1 is a direct substrate of Parkin.
Similar to hMiro1, hMiro2 could also be ubiquitinated by
PINK1 and Parkin co-expression or after CCCP treatment.
However, the degradation of hMiro2 was at a much slower rate
compared to hMiro1 (Figure S1), consistent with a previous result
[40]. Furthermore, like exogenous hMiro1, endogenous hMiro1
was also rapidly degraded by PINK1/Parkin overexpression in
HeLa cells and its level was dramatically reduced within 15 min of
CCCP treatment. The degradation of endogenous hMiro2 was
again at a much slower rate than that of hMiro1 (Figure 5C, 5D).
We next examined the effect of the PINK1/Parkin pathway on
Miro protein level in an in vivo setting. Similar to the results in
HeLa cells, Drosophila dMiro protein level was decreased in the
brain extracts of PINK1 or Parkin overexpression adult flies
(Figure 5E). Conversely, dMiro level was increased in PINK1
B9
mutant brain extracts (Figure 5E). These results are consistent with
dPINK1 negatively regulating dMiro protein level in vivo.I ti s
worth noting that different from the effects seen in HeLa cells,
overexpression of PINK1 or Parkin alone was sufficient to reduce
dMiro level in adult Drosophila brain, and the co-expression of
PINK1 and Parkin did not lead to much further reduction of
dMiro level than PINK1-OE alone, suggesting that the endoge-
nous levels or activities of PINK1 and Parkin are already sufficient
to support each other’s action in the Drosophila brain.
Knockdown of Miro promotes the removal of damaged
mitochondria by Parkin-mediated mitophagy
Removal of damaged or dysfunctional mitochondria through
mitophagy could be one mechanism by which the PINK1/Parkin
pathway maintains mitochondrial health, at least under some
Figure 3. PINK1 regulates mitochondrial motility in Drosophila larval motor neurons. (A) An image of a third instar larva expressing
mitoGFP in the motor neurons. For time-lapse imaging, mitochondrial movement in segmental nerves (SN) was recorded near the ventral ganglion
(VG) (indicated by the white box). (B) Representative kymographs of mitochondrial movement in the different genetic backgrounds. Each panel is a
kymograph representation of the position of fluorescently labeled mitochondria as a function of time. Anterograde mitochondrial movements have
positive slopes, whereas retrograde mitochondrial movements have negative slopes. Stationary mitochondria appear as vertical streaks. (C, D)
Mitochondrial flux (C) and net velocity (D) in different genetic backgrounds. (E, F) Average mitochondrial length (E) and mitochondrial length
distribution (F) in the various genetic backgrounds. Data are presented as mean 6 s.e.m.
doi:10.1371/journal.pgen.1002537.g003
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in PINK1 mutants could be the underlying cause of disease
pathogenesis. Consistent with this notion, it was previously shown
that enhancing autophagy could efficiently rescue dPINK1 mutant
phenotypes [35]. To better understand the rescuing effect of Miro-
RNAi in PINK1 mutant background, we examined the effect of
Miro knockdown on mitophagy. We used CCCP treatment to
induce mitochondrial damage in HeLa cells stably transfected with
venus-Parkin, and subsequently monitored the removal of
damaged mitochondria over time by examining the protein levels
of mitochondrial markers on the inner/outer membrane or in the
matrix and inter-membrane space. Simultaneous knockdown of
hMiro1 and hMiro2 significantly accelerated the mitochondrial
removal process, with all the mitochondrial markers disappearing
faster in hMiro knockdown cells than in the control siRNA-treated
cells (Figure 6A). This suggested that there was more active
mitophagy after hMiro knockdown. To confirm this result, we
monitored the mitochondrial network by immunofluorescence
staining. Compared to the control siRNA-treated cells, knockdown
of either hMiro1 or hMiro2 led to the accumulation of
mitochondria in the perinuclear region, and knockdown of both
hMiro1 and hMiro2 further enhanced this effect (Figure 6B).
Fluorescence from the immunostaining of Tom20 (an OMM
marker) but not HSP60 (a matrix marker) in hMiro1 and hMiro2
double knockdown cells was noticeably weaker than that in control
siRNA treated cells at 3 h after CCCP treatment (Figure 6C),
supporting the notion that hMiro knockdown facilitated an early
event in Parkin-mediated mitophagy.
The conserved Ser-156 residue in hMiro1 is not required
for PINK1/Parkin-mediated degradation under normal or
CCCP treatment conditions in HeLa cells
We further investigated the molecular mechanisms by which the
PINK1/Parkin pathway regulates Miro protein level or stability.
While our paper was under review, a report showed that PINK1
phosphorylates Miro at a conserved S156 residue, and that this
phosphorylation activates proteasomal degradation of Miro in a
Parkin-dependent manner [34]. However, repeated in vitro kinase
assays using an active GST-dPINK1 recombinant protein capable
of efficient autophosphorylation [42] failed to show phosphoryla-
tion of GST-dMiroDTM, a GST fusion protein of full-length
dMiro with the transmembrane domain deleted (Figure 7A).
Drosophila or mammalian PINK1 protein affinity purified from
HEK293 cells by immunoprecipitation also failed to phosphory-
late GST-dMiroDTM in our assays (data not shown).
To further probe the significance of S156 phosphorylation in
facilitating the proteasomal degradation of Miro promoted by the
PINK1/Parkin pathway, we introduced S156A mutations into
hMiro1 or hMiro2 and examined the stability of the mutant
proteins in HeLa cells co-transfected with PINK1 and Parkin,
under normal or CCCP treatment conditions. As shown in
Figure 7B, the wild type and S156A mutant forms of hMiro1 were
equally susceptible to PINK1/Parkin- mediated degradation
under both conditions. The wild type and S156A mutant forms
of hMiro2 behaved similarly as well (data not shown). Thus, the
PINK1/Parkin pathway may regulate Miro protein level inde-
Figure 4. PINK1 affects mitochondrial distribution within motor neuron nerve terminals at the Drosophila larval neuromuscular
junction. Pan-neuronal elav-Gal4 driver was used to express mitoGFP in different genetic backgrounds to examine the mitochondrial distribution at
the neuromuscular junction (NMJ) of muscle 6/7 in A3-A4 segments. Anti-GFP antibody (Green) and anti-HRP-Texas Red antibody (Red) were used to
visualize mitochondria and boutons, respectively. (A) Representative images of mitochondrial distribution at the NMJs of wild type, PINK1-OE, PINK1-
RNAi, Miro-RNAi and Miro-OE flies were shown in the left panels. Detailed mitochondrial distribution of the boxed areas in the left panels was shown
in the right panels. (B) PINK1 regulates mitochondrial distribution at the NMJ. Mitochondrial density of each bouton was estimated by its average GFP
fluorescence intensity, represented as total GFP green fluorescence (anti-GFP staining) of each bouton/bouton size (HRP-Texas Red staining).
Mitochondrial density ratio of the most distal bouton versus the next 4 boutons was used to quantitatively compare mitochondrial distribution at the
NMJ. Compared to the control, PINK1 knockdown showed significant accumulation of mitochondria at the most distal bouton, although its effect was
not as strong as Miro-OE. In contrast, Miro-RNAi and PINK1-OE both led to reduced mitochondrial mass in the most distal boutons.
doi:10.1371/journal.pgen.1002537.g004
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conditions in HeLa cells.
Effect of loss of PINK1 function on Miro protein level in
mammalian cells
We also examined the effect of loss of PINK1 function on Miro
protein level in mammalian cells. For this purpose, we used both
HeLa cells with PINK1 knockdown and MEF cells derived from
PINK1 (2/2) knockout mice. Surprisingly, unlike the situation in
Drosophila, endogenous Miro1 or Miro2 protein levels were
significantly reduced in PINK1 RNAi cells under normal or
CCCP treatment conditions (Figure 7C, PINK1 RNAi in HeLa
cells or Venus-Parkin stably transfected HeLa cells) and in PINK1
(2/2) MEF cells (Figure 7D). The introduction of Venus-Parkin
resulted in CCCP/PINK1-dependent degradation of Miro1
(Figure 7C, Control RNAi in Venus-Parkin transfected HeLa
cells). Thus, loss of PINK1 function in mammalian cells can lead
to reduced expression of Miro1 and Miro2 proteins, presumably
through mechanisms distinct from that operating under PINK1/
Parkin co-overexpression condition.
Discussion
Mitochondrial dysfunction has long been implicated in the
pathogenesis of PD. However, the exact mechanisms by which
mitochondrial dysfunction arises in the disease process and how
cells, particularly neurons, handle dysfunctional mitochondrial are
not well understood. The identification of a mitochondrial quality
control system involving two FPD genes, PINK1 and Parkin, has
provided a much-needed point of entry to elucidate the role of
mitochondria in the pathogenesis of PD. Here we showed that
PINK1 directly regulates mitochondrial transport and that it
affects the stability and/or activity of Miro, a mitochondrial Rho
GTPase with a well-establish function in mitochondrial transport.
Our conclusion is supported by the following evidence: 1) dMiro
protein level is negatively regulated by PINK1 and Parkin in vivo in
Drosophila; 2) Overexpressed PINK1 and Parkin act together to
promote the ubiquitination and degradation of hMiro1 in HeLa
cells; 3) Reduction of the activities of Miro or other components of
the mitochondrial transport machinery effectively rescued dPINK1
mutant phenotypes. 4) Overexpression of dMiro in DA neurons
phenocopied dPINK1 loss-of-function effects; 5) Manipulation of
dPINK1 activity produced clear mitochondrial motility pheno-
types opposite to that observed for dMiro manipulation in
Drosophila larval motor neurons. Together, these results support
that the mitochondrial transport defects caused by PINK1
inactivation represent one of the key pathogenic events that
contribute to PD pathogenesis in the Drosophila model.
Neurons are highly polarized cells that rely heavily on axonal
transport to distribute to axons and synapses critical proteins and
organelles synthesized in the cell body, thereby maintaining
neuronal function and health. Defects in axonal transport are
often linked to diseases affecting peripheral neurons that tend to
extend very long axons [21,22,29]. Although the symptoms of PD
patients mainly arise from the loss of DA neurons, some PD
patients carrying particular PINK1 and Parkin mutations developed
peripheral neuropathy with unknown cause [18–20]. Our results
showing the PINK1/Parkin pathway playing a critical role in
regulating mitochondrial transport offers one potential explana-
tion of the peripheral neuropathy symptoms observed in these
Figure 5. PINK1/Parkin regulates the ubiquitination and stability of Miro protein. (A) Effects of hPINK1 and hParkin on the ubiquitination
and protein stability of exogenous hMiro1 in HeLa cells. Cells transfected with the indicated plasmids were treated with or without 10 mM CCCP for
90 min. Arrowheads, Parkin or PINK1 co-precipitated with hMiro1; Asterisks: oligo-ubiquitinated hMiro1. The inner mitochondrial membrane protein
COX I and the mitochondrial matrix protein Hsp60 are used as loading controls for mitochondrial proteins. b-actin serves as a loading control for
cytosolic proteins. (B) Effects of mutant hPINK1 or hParkin on hMiro1 protein level in HeLa cells. The Parkin K211N mutation in the linker domain is
reported to lack both ubiqutin-ligase (E3) and mitochondrial translocation activities, while the Parkin T415 mutation in the RNIG2 domain, which
disrupts E3 activity, retains partial mitochondrial translocation activity [56]. The PINK1 L347P mutant is reported to have reduced kinase activity [57].
An OMM protein VDAC1 is shown as a loading control for mitochondrial proteins. (C, D) Time-course experiments examining the effects of hPINK1/
hParkin on the stability of endogenous hMiro1/2 proteins. Specificity of the hMiro antibodies was confirmed using hMiro knockdown cells (C). (E)
Endogenous dMiro level in fly brain extracts of the various genetic backgrounds. elav-Gal4 was used to drive the expression of the transgenes.
Normalized dMiro level compared to wild type control was shown as mean 6 s.e.m. (n=3).
doi:10.1371/journal.pgen.1002537.g005
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examine whether Miro protein level or activity is affected by these
particular mutations in human cells. Moreover, we propose that
defects in PINK1/Parkin-regulated mitochondrial transport may
offer one explanation of the selective vulnerability of DA neurons
observed in PD patients and animal models. DA neurons that
make elaborate and long projections may be particularly
vulnerable to impairment of the mitochondrial transport system.
Our results offer new insights into the mode of action of the
PINK1/Parkin pathway in mitochondria quality control. We
showed that, in Drosophila models, PINK1 OE led to decreased
mitochondrial flux and net velocity, as observed in Miro
knockdown background. In addition, we found that Miro
knockdown could facilitate an early step of mitophagy in
mammalian cells. These observations, together with the finding
that the normally labile PINK1 protein is stabilized on damaged
Figure 6. Miro knockdown facilitates the removal of damaged mitochondria by Parkin-mediated mitophagy. (A) Time course of CCCP
treatment to monitor mitophagy in Hela cells stably transfected with Venus-Parkin. Cells were transfected with control siRNA or hMiro1+hMiro2
siRNAs and treated with 10 mM CCCP for the indicated time. Markers for mitochondrial outer membrane (Tom20, VDAC1), intermembrane space
(HtrA2/Omi, Cyt c), inner membrane (Tim23, NDUFA9), and matrix (PDHA1, Hsp60) were examined by Western blot to determine the elimination of
damaged mitochondria. b-actin was used as a loading control. (B) Immunofluorescence staining showing the formation of perinuclear mitochondrial
aggregates after siRNA-mediated knockdown of hMiro1 or hMiro2. HeLa cells transfected with control siRNA, hMiro1 siRNA, hMiro2 siRNA, or
hMiro1+hMiro2 siRNAs were stained for Tom20 and a-tubulin. Merged images are shown to the right. Insets show enlarged view of mitochondrial
morphology in the boxed areas. Arrowheads indicate ring-like or round-shaped mitochondria. (C) Miro knockdown facilitates the early stage of
mitophagy in venus-Parkin transfected HeLa cells treated with CCCP. HeLa cells stably transfected with venus-Parkin were co-transfected with control
siRNA or hMiro1+hMiro2 siRNAs and then treated with the DMSO vehicle or CCCP for 90 mins or 3 hrs. Venus-Parkin (blue), Tom20 (green), and
Hsp60 (red) were visualized by immunostaining. Merged Tom20/Hsp60 signals are shown to the right. Cells of interest are outlined.
doi:10.1371/journal.pgen.1002537.g006
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of PINK1 on damaged mitochondria and the subsequent turnover
of Miro could exert neuroprotection by (1) preventing damaged
mitochondria from being anterogradely transported along the
axons, thus increasing their chance of getting eliminated in the
soma; and (2) promoting elimination of damaged mitochondria
through mitophagy. This potentially explains the normal protec-
tive function of PINK1. When PINK1 function is impaired,
however, on one hand mitochondria become dysfunctional as
evidenced by morphology changes and impaired electron
transport chain function [3–5,33,43–45], on the other hand, the
anterograde mitochondrial transport is enhanced as shown in this
study in Drosophila models. As a result, the dysfunctional
mitochondria would have increased retention in the axons and
synapses, resulting in increased reactive oxygen species (ROS)
production, oxidative damage, and subsequent synaptic and
axonal degeneration and eventual neuronal loss, at least in the
Drosophila models. Many details of this model await further
experimental validation. For example, it has been suggested that
the reported effect of PINK1/Parkin on mitochondrial autophagy
may not operate in the same manner in primary neurons as
compared to cultured non-neuronal cells [46]. It also remains to
be determined whether the effects of Miro on mitochondrial
transport and mitophagy reflect a functional antagonism between
these two processes, or two distinct functions of Miro in neuronal
maintenance. In this respect, it is worth noting that the effect of
Miro overexpression on cell survival in Drosophila is cell type-
dependent: it causes DA neuron loss but has no obvious effect on
muscle integrity (data not shown). It is possible that different tissues
may have different sensitivities to impairments of Miro function.
For example, muscle cells may be less susceptible to mitochondrial
transport defects than neurons.
One interesting difference we observed between Drosophila and
mouse systems was that although activation of the PINK1/Parkin
pathway led to reduced Miro protein level in both systems, the loss
of PINK1 in Drosophila resulted in increased steady-state Miro
proteinlevel,whereasitslossinmammaliancellsasinPINK1(2/2)
MEF cells or PINK1 RNAi HeLa cells had the opposite effect. The
mechanism of Miro downregulation in PINK1 loss-of-function
mammalian cells is currently unknown, but it is presumably
different from that used by activation of the PINK1/Parkin
pathway. Since the upregulation of dMiro in dPINK1 mutant
background is likely causal to DA neuron degeneration, as
indicated by the rescue of DA neuron loss in dPINK1 mutant by
dMiro-RNAi and the induction of DA neuron loss by dMiro-
OE alone, it is tempting to speculate that the downregulation of
Miro levels in PINK1 (2/2) mouse, as opposed to the dMiro
upregulation in Drosophila PINK1 mutant, might contribute to
the lack of DA neuron degeneration phenotype in the mouse
PINK1 models [47–50]. Testing this hypothesis will require in
Figure 7. Effects of PINK1 loss of function on endogenous Miro protein level in mammalian cells and testing potential direct
phosphorylation of Miro by PINK1. (A) Lack of direct phosphorylation of GST-dMiroDTM by 26 GST-dPINK1. Autoradiography (P
32) and
Coomassie Brilliant Blue (CBB) staining of the same SDS-PAGE gel of the in vitro kinase reactions were shown. The presence of the GST-dMiroDTM and
26GST-dPINK1 proteins was further confirmed by Western blot with anti-GST. The detected P
32 signals represent PINK1 autophosphorylation. (B)
Western blot analysis comparing the stability of transfected Myc-hMiro1-wild type (wt) and Myc-hMiro1-S156A in HeLa cells with or without CCCP
treatment and in the presence or absence of hPINK1+hParkin co-expression. (C) Western blot analysis of HeLa cells or Venus-Parkin stably transfected
HeLa cells with or without CCCP treatment under control RNAi or PINK1 RNAi conditions. (D) Western blot analysis of mouse Miro1 and Miro2 levels in
wild type or PINK1 knockout (KO) MEF cells. Extracts were treated with or without lambda phosphatase before Western blot analysis. Note that
whereas the signals for a control phsopho-ATF1 (p-ATF1) protein disappeared after lambda phosphatase treatment, neither Miro1 nor Miro 2 showed
mobility or intensity change after the same treatment.
doi:10.1371/journal.pgen.1002537.g007
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PINK1 (2/2) mouse.
Our results also provide new insights into the process by which
the PINK1/Parkin pathway promotes mitophagy. Previous studies
suggested that upon recruitment to damaged mitochondria, Parkin
activates the ubiquitin proteasome system to effect wide-spread
degradation of OMM proteins in an autophagy-independent
manner, and it was further proposed that this remodeling of
OMM is important for a subsequent step of mitophagy [40]. The
previously identified Parkin substrates, Mfn1 and Mfn2, although
important for the effect of Parkin on mitochondrial fission/fusion
dynamics, are not necessary for Parkin-induced mitophagy
[40,51]. Here we show that removal of Miro by the PINK1/
Parkin pathway, in a presumably autophagy-independent but
ubiquitination-dependent manner, facilitated mitophagy. Interest-
ingly, knockdown of mammalian Miro itself promotes the
formation of ring-like or round-shaped mitochondrial morpholo-
gy, which is often observed in depolarized, mitophagy-ready
mitochondria (Figure 6B; [13]). It is possible that the removal of
Miro from OMM exposes certain recognition signals for the
autophagy machinery, or that Miro/Milton/Kinesin-mediated
mitochondrial transport may normally antagonize the mitophagy
process. Supporting the latter scenario, an interaction between the
BECLIN 1-interacting protein AMBRA1 and the dynein motor
complex has been implicated in mammalian autophagy [52]. It
also remains to be understood at the mechanistic level how PINK1
cooperates with Parkin to promote the ubiquitination and
degradation of Miro. One attractive hypothesis is that PINK1
may directly phosphorylate Miro to promote its subsequent
ubiquitination and degradation by Parkin, as suggested by a
recent study [34]. However, our biochemical data have so far
failed to support this hypothesis. It is possible that the divergent
results are due to the different cell lines used or other experimental
conditions. Alternatively, PINK1 may directly act on Parkin to
promote Parkin’s mitochondrial recruitment or activity in
activating ubiquitin proteasome system-mediated ubiquitination
and degradation of Miro. Further studies are needed to elucidate
the molecular mechanisms of PINK1/Parkin action.
Finally, it is worth mentioning that studies in Drosophila models
have identified a number of genetic modifiers of PINK1/Parkin
[35,53,54]. While some of these genetic modifier genes may be
directly related to the seemingly diverse biological activities of the
PINK1/Parkin pathway, possibly mediated by distinct PINK1/
Parkin substrates, others may reflect cellular compensatory
responses to cope with the mitochondrial dysfunction caused by
PINK1/Parkin inactivation. The fact that manipulations of each
of these different cellular processes exert clear functional rescue of
PINK1/Parkin mutant phenotypes suggests that there exists a
signaling network linking the diverse activities of PINK1/Parkin in
mitochondria biology with the nuclear-encoded cellular responses
to mitochondrial dysfunction, and that many key players in this
network represent novel and rational therapeutic targets.
Materials and Methods
Fly strains and reagents
Flies were raised according to standard procedures at indicated
temperatures. Sources of fly strains and other reagents are as
follows: dPINK1
B9: Dr. J. Chung [3]; UAS-dMiro and anti-dMiro
antibody: Dr. K. Zinsmaier [31]; TH-GAL4, UAS-PINK1, UAS-
PINK1 RNAi and rabbit anti-Drosophila TH antibody: described
before [5]; UAS-Miro RNAi
106683: Vienna Drosophila RNAi Center;
UAS-Miro RNAi
27695, UAS-Milton RNAi
28385 and UAS-Khc
RNAi
25898: Harvard Transgenic RNAi Project (TRiP) and
Bloomington Drosophila Stock Center; all other fly lines: Bloo-
mington Drosophila Stock Center; FLAG-hParkin mutants and HA-
ubiquitin: Drs. N. Matsuda, K. Tanaka and S. Hatakeyama; Myc-
hMiro1 and Myc-hMiro2 plasmids: Dr. P. Aspenstro ¨m [30];
hPINK1 cDNAs were cloned into pcDNA3-FLAG vector.
Antibodies used in this study are as follows: anti-RHOT1/
Miro1 (4H4, Abnova), anti-RHOT2/Miro2 (Protein technology
Group), anti-PINK1 (Novus), anti-Parkin (PRK8, Santa Cruz
Biotechnology), anti-Tom20 (FL-145, Santa Cruz Biotechnology),
anti-VDAC1 (Abcam), anti-OXPHOS Complex IV subunit I/
COX I (Invitrogen), anti-Tim23 (BD), anti-NDUFA9 (Invitrogen),
anti-Cytochrome c (BD), anti-HtrA2/Omi (as described in [55]),
anti-Hsp60 (BD), anti-PDHA1 (Abcam), anti-HA (3F10, Roche),
anti-Myc (4A6, Millipore; #2272, Cell Signaling Technology),
anti-b-actin (AC-15, Sigma-Aldrich), anti-a-tubulin (DM1A,
Millipore), Peroxidase anti-Guinea Pig IgG antibody (Jackson
ImmunoResearch), Texas Red-conjugated anti-HRP (Jackson
ImmunoResearch), Alexa Fluor 488 nm-conjugated goat anti-
chicken IgG (Invitrogen) and Alexa Fluor 594 nm-conjugated goat
anti-rabbit IgG (Invitrogen).
Fly wing posture, behavior, ATP measurement, and
immunohistochemistry
These assays were carried out essentially as described before
[35]. The thoracic ATP level was measured using a luciferase
based bioluminescence assay (ATP Bioluminescence Assay Kit HS
II, Roche applied science) as described [35].
Whole-mount brain immunohistochemistry for TH and mi-
toGFP was performed as described previously [35]. For DA
neuron mitochondrial morphology analysis, mitoGFP was ex-
pressed in Drosophila DA neurons using the TH-Gal4 driver. Brains
from 3-day-old adult flies of the indicated genotypes were
immunostained with the anti-TH antibody to label DA neuron
and anti-GFP antibody to label mitochondria. For measurement of
mitochondrial size distribution, the size of each mitochondrial
aggregate was represented by the length of its longest axis. The
percentage of DA neurons in the PPL1 cluster that have one or
more mitochondria exceeding the indicated size was shown. Six
flies of each genotype were used for the analysis.
Live imaging of mitochondrial movement
The motor neuron-specific OK6-Gal4 driver was used to express
UAS-mitoGFP in the larval segment neurons, and 3
rd instar male
larvae raised at 29uC were used for live imaging. Larvae were
briefly washed with water and anesthetized for 4 min in 1.5 ml
eppendorf tubes containing 4 ml suprane (Baxter International
Inc.), before being placed ventral side up into a small chamber.
The chamber was created on glass slide with double-sided tape
and cover glass. Additional suprane (4 ml) was introduced into the
chamber before it was sealed with Valap (1:1:1 amount of vaseline,
lanolin, parafin wax). Mitochondria were viewed with an upright
Leica DM6000 B microscope equipped with a laser scanner and a
636oil-immersion objective. Larvae were positioned to have their
ventral ganglion (VG) appearing on the right of the acquired
image and segmental nerves aligned horizontally across the image.
Before recording mitochondrial movement, a centered region of
10246200 pixel (61.5 mm612.0 mm, 46digital zoom) close to the
VG was photobleached for 30 s with 488 nm excitation argon
laser set at 80% output power. The viewing field was then zoomed
out (2.56 digital zoom) and mitochondrial movement was
immediately recorded by time-lapse video (2 s/frame, 300 s total)
in a region of 10246150 pixel (98.4 mm614.4 mm) with the laser
power reduced to 10% of the maximum output. The pinhole was
set at 200 mm for all the experiments. Time-lapse images were
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calculated by normalizing the number of mitochondria that passes
certain point within the time frame examined. Mitochondrial net
velocity was calculated by normalizing mitochondrial net dis-
placement with time. At least 5 larvae of each genotype were
analyzed.
Cell culture and transfection
HeLa cells were maintained at 37uC with 5% CO2 atmosphere
inDMEM(Wako)supplementedwith 10%FCS(GIBCO)andnon-
essential amino acids (Invitrogen). Plasmids and siRNA duplexes
(Invitrogen) were transfected using Lipofectamine 2000 (Invitrogen)
and Lipofectamine RNAiMAX (Invitrogen), respectively, according
to manufacturer’s instructions. To depolarize the mitochondria,
HeLa cells were treated with 10 mM CCCP (Sigma-Aldrich) at
36 hr (for plasmids) or 72 hr (for siRNA) post-transfection.
The S156A mutations were introduced into human Miro1 and
Miro2 by PCR-based mutagenesis using the following primers: For
hMiro1, Forward primer: 59- GCA gag ctcttttatt acgcac -39;
Reverse primer: 59- tatg ttcttcaggt ttttcgc -39. For hMiro2,
Forward primer: 59- GCA gagct gttctactac gc -39; Reverse primer:
59- ga tgttcctcag gttcttggc -39. Full-length sequences of hMiro1
S156A and hMiro2 S156A were confirmed by sequencing.
Immunoblotting, immunoprecipitation, and in vitro
phosphorylation
For brain extract preparation, 6 fly heads were quickly dissected
and homogenized in 60 ml SDS-PAGE sample buffer. 5 ml brain
extracts from each genotype were loaded onto SDS-PAGE gel.
Guinea pig anti-dMiro antibody (1:20000, from Dr. K. Zinsmaier)
and Peroxidase Anti-Guinea Pig IgG antibody (1:10000, Jackson
ImmunoResearch Labs) were used for Western Blot. For HeLa
cell-based biochemical analysis, cells were lysed in 1% Triton X-
100 -based lysis buffer (10 mM Tris-HCl [pH 7.6], 120 mM
NaCl, 5 mM EDTA, 1% Triton X-100 and protease inhibitor
[Nacalai Tesuque]). Immunoprecipitation was performed using
Immunoprecipitation Kit-Dynabeads Protein G (Invitrogen)
according to manufacturer’s instructions.
In vitro kinase assay was performed essentially as described [42],
using a 26GST-dPINK1 fusion protein with GST fused at both
the N- and C-terminus of dPINK1 as the kinase source and a
GST-dMiroDTM fusion protein as the substrate. GST-dMir-
oDTM covers amino acids 1–634 of the full-length dMiro protein.
The GST-dMiro-DTM plasmid was constructed by amplifying a
Myc-tagged dMiro fragment without the transmembrane domain
from a pUAST-Myc-dMiro plasmid (obtained from Dr. K.
Zinsmaier) using 59-CGCCCG-GGTGAGCAGAAACTCATC-
TCTGAAGAAG-39 and 59-ATGCGGCCGCTACTTGGG-
GTCCTCCGTC-ATC-39 as primers. The amplified fragment
was inserted into the SmaI and NotI cloning sites of the pGEX-6P-1
vector. Recombinant GST fusion proteins were purified from
bacteria according to standard protocols.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in PBS and
permeabilized with 0.2% Triton X-100 (for mitophagy in
Figure 6C) or 0.5% Triton X-100 (for mitochondrial morphology
in Figure 6B) in PBS. Cells stained with the appropriated
antibodies and counterstained with DAPI were imaged using a
laser-scanning microscope (LMS510 META; Carl Zeiss, Inc.) with
a Plan-Apochromat 636NA1.4 or 1006/1.4 Oil differential
interference contrast objective lens. Image contrast and brightness
were adjusted in Image Browser (Carl Zeiss, Inc.)
Statistical analysis
Two-tailed Student’s t tests were used for statistical analysis. p
values of ,0.05, ,0.01, and ,0.005 were indicated with one, two,
and three asterisks (*), respectively.
Supporting Information
Figure S1 hMiro2 on damaged mitochondria is ubiquitinated by
PINK1 and Parkin. (a) HeLa cells transfected with the indicated
plasmids were treated with or without 10 mM CCCP for 90 min.
Immunoprecipitate of hMiro2 was analyzed for poly-ubiquitina-
tion modification and co-precipitation of PINK1 and Parkin.
Arrowheads, co-precipitated Parkin or PINK1 with hMiro2;
Asterisks, oligo-ubiquitinated hMiro2 detected by anti-Myc
antibody. (b) Pathogenic mutant forms of PINK1 or Parkin
abolished hMiro2 ubiquitination. The ubiquitination assay was
performed as in (a). The Parkin K211N mutation in the linker
domain is reported to abolish both its E3 ubiqutin-ligase activity
and its ability to translocate to damaged mitochondria. The Parkin
T415 mutation in the RNIG2 domain disrupts its E3 activity,
while partially retaining its mitochondrial translocation ability
[56]. The PINK1 L347P mutant is reported to have reduced
kinase activity [57].
(TIF)
Video S1 Mitochondrial movement in the axons of wild-type
Drosophila larval segment neurons. Representative time-lapse video
of mitochondrial movement in a segment neuron of wild-type
Drosophila larva is shown. Mitochondrial movement was visualized
by the mitoGFP fluorescence. Mitochondrial movement to the left
represents anterograde axonal transport. The video was acquired
at a speed of 2 sec/frame and played at 4 frames/sec (1 s movie
time=8 s real time).
(AVI)
Video S2 PINK1-OE arrests mitochondrial movement in the
axons of Drosophila larval segment neurons. Representative time-
lapse video of mitochondrial movement in a segment neuron of
PINK1-OE Drosophila larva is shown. Mitochondrial movement
was visualized by the mitoGFP fluorescence. PINK1-OE decreases
mitochondrial length and flux in both anterograde and retrograde
directions. Mitochondrial movement to the left represents
anterograde axonal transport. The video was acquired at a speed
of 2 sec/frame and played at 4 frames/sec (1 s movie time=8 s
real time).
(AVI)
Video S3 PINK1-RNAi promotes anterograde mitochondrial
movement in a Drosophila larval segment neuron axon. Represen-
tative time-lapse video of mitochondrial movement in a segment
neuron of PINK1-RNAi Drosophila larva is shown. Mitochondrial
movement was visualized by the mitoGFP fluorescence. PINK1-
RNAi increases mitochondrial length and anterograde mitochon-
drial flux and movement speed. Mitochondrial movement to the
left represents anterograde axonal transport. The video was
acquired at a speed of 2 sec/frame and played at 4 frames/sec (1 s
movie time=8 s real time).
(AVI)
Video S4 Miro-RNAi arrests mitochondrial movement in the
axons of Drosophila larval segment neurons. Representative time-
lapse video of mitochondrial movement in a segment neuron of
Miro-RNAi Drosophila larva is shown. Mitochondrial movement
was visualized by the mitoGFP fluorescence. Miro-RNAi decreas-
es mitochondrial length and flux in both anterograde and
retrograde directions. Mitochondrial movement to the left
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at a speed of 2 sec/frame and played at 4 frames/sec (1 s movie
time=8 s real time).
(AVI)
Video S5 Miro-OE increases mitochondrial movement speed in
the axons of Drosophila larval segment neurons. Representative
time-lapse video of mitochondrial movement in a segment neuron
of Miro-OE Drosophila larva is shown. Mitochondrial movement
was visualized by the mitoGFP fluorescence. Miro-OE increases
mitochondrial length and anterograde movement speed. Mito-
chondrial movement to the left represents anterograde axonal
transport. The video was acquired at a speed of 2 sec/frame and
played at 4 frames/sec (1 s movie time=8 s real time).
(AVI)
Video S6 Fis1-OE promotes mitochondrial flux in the axons of
Drosophila larval segment neurons. Representative time-lapse video
of mitochondrial movement in a segment neuron of Fis1-OE
Drosophila larva is shown. Mitochondrial movement was visualized
by the mitoGFP fluorescence. Overexpression of the mitochon-
drial fission protein Fis1 (FIs1-OE) decreases mitochondrial length
but increases mitochondrial flux in both anterograde and
retrograde directions. Mitochondrial movement to the left
represents anterograde axonal transport. The video was acquired
at a speed of 2 sec/frame and played at 4 frames/sec (1 s movie
time=8 s real time).
(AVI)
Video S7 Marf-RNAi promotes mitochondrial flux in the axons
of Drosophila larval segment neurons. Representative time-lapse
video of mitochondrial movement in a segment neuron of Marf-
RNAi Drosophila larva is shown. Mitochondrial movement was
visualized by the mitoGFP fluorescence. Knockdown of the
mitochondrial fusion protein Marf (Marf-RNAi) decreases mito-
chondrial length but increases mitochondrial flux in both
anterograde and retrograde directions. Mitochondrial movement
to the left represents anterograde axonal transport. The video was
acquired at a speed of 2 sec/frame and played at 4 frames/sec (1 s
movie time=8 s real time).
(AVI)
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